Tue, Aug 4, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

RUMOUR: Infinium Global not reachable, not returning money to investor

Wednesday, June 12, 2013

Benedicte Gravrand, Opalesque Geneva:

An investor has alerted Opalesque of a fund whose managers are unreachable and not returning his redeemed money. Here, we report his story.

The Infinium Global Fund launched in July 2010 with a foreign currency-related trading strategy developed by two brothers and co-directors Andriy and Anto Kalyta. The $19.7m fund reportedly returned +43% in 2010, +104% in 2011, +77% in 2012 and +18% in 2013 (to May). The two brothers run the fund from Bratislava, the capital of Slovakia, and their registered office is in Grand Cayman.

An Asia-based investor alerted Opalesque about an investment he had made in Infinium where he bought 100 shares in August 2011, followed by a redemption request he sent to Infinium during the first week of April 2013. The shares’ NAV amounted $2,384 by the end of April. Lukas Matiasko, Investor Relations at Infinium, assured him he would receive his redemption in early May. As the redemption was late in coming, Andriy Kalyta then assured the investor he would get his money back in late May.

According to the fund’s Offering Memorandum, the minimum initial subscription amount per investor must be $100,000 (and $100,000 subsequently), the price per share was $1,000, the redemption notice period is monthly, and the fund "may defer payment of the redemption price if it is unable to do so because of circumstances beyond its control."

As no money ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  2. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  3. Performance - Some hedge fund small-cap energy stocks have been free falling, Dan Loeb's simple strategy destroys the market, Baupost lost 1.4% last quarter as energy bargains proved elusive[more]

    Some hedge fund small-cap energy stocks have been free falling From Marketrealist.com: According to a July 28, 2015, Bloomberg article, there was a 34% fall in small-cap energy stocks over the past three months. These shares are tracked by the Russell 2000 Energy Index. Small-cap energy

  4. Legal - Hedge funds hit Rothstein Kass with $75m malpractice suit, JPMorgan questioned on private bank’s hedge fund disclosures, Kijani fund, seized by regulators in Cayman Islands, spotlights risks in lightly regulated market[more]

    Hedge funds hit Rothstein Kass with $75m malpractice suit From Law360.com: Two investment funds have sued Rothstein Kass & Co. PC for at least $75 million, claiming the New Jersey auditing firm committed accounting malpractice by failing to properly scrutinize overblown valuations of the

  5. Assets - Hedge funds are getting smoked by the commodities slump, Global ETF assets could more than double by 2020[more]

    Hedge funds are getting smoked by the commodities slump From Businessinsider.in: The collapse in commodity prices has burnt another hedge fund. Vermillion, a commodity hedge fund backed by Carlyle Group, has seen its flagship fund's assets fall from nearly $2 billion to less $50 million,

 

banner